Common Stock, Shares, Outstanding of Kalaris Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kalaris Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Kalaris Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 18,702,418, a 84% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Kalaris Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 18,702,418 -96,735,701 -84% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 18,702,418 -96,609,993 -84% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 18,702,418 -96,179,347 -84% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 1,356,431 -3,606,566 -73% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 115,438,119 +1,471,525 +1.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 115,312,411 +1,596,393 +1.4% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 114,881,765 +21,453,775 +23% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 4,962,997 -88,130,246 -95% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 113,966,594 +21,326,485 +23% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 113,716,018 +48,927,915 +76% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 93,427,990 +29,163,863 +45% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 93,093,243 +29,527,357 +46% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 92,640,109 +29,462,181 +47% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 64,788,103 +1,996,060 +3.2% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 64,264,127 +1,813,033 +2.9% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 63,565,886 +1,634,631 +2.6% 31 Dec 2021 10-K 15 Feb 2023 2022 FY
Q3 2021 63,177,928 +1,518,395 +2.5% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 62,792,043 +59,990,184 +2141% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 62,451,094 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 61,931,255 +59,831,515 +2849% 31 Dec 2020 10-K 10 Feb 2022 2021 FY
Q3 2020 61,659,533 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 2,801,859 30 Jun 2020 10-Q 02 Sep 2020 2020 Q2
Q4 2019 2,099,740 31 Dec 2019 10-K 12 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.